Which closed-end funds own Alkermes PLC?
8 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $22.3M. Security type: common equity. Country: Ireland. CUSIP G01767105 · ISIN IE00B56GVS15 · ticker ALKS.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.81% | $8.7M | 166,685 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 0.27% | $2.8M | 54,000 sh | $1.1B | 7.7% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.27% | $3.7M | 69,693 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| THW abrdn World Healthcare Fund | Healthcare | 0.27% | $1.8M | 35,087 sh | $689M | 4.3% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.27% | $1.8M | 35,025 sh | $690M | 3.5% discount | Jun 30, 2026 |
| RVT Royce Small-Cap Trust | U.S. Equity | 0.12% | $3M | 58,072 sh | $2.6B | 14.0% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.11% | $262K | 5,000 sh | $228M | NAV unavailable | Jun 30, 2026 |
| SPXX Nuveen S&P 500 Dynamic Overwrite Fund | Covered Call / Option Income | 0.00% | $129K | 2,460 sh | $2.9B | NAV unavailable | Jun 30, 2026 |
8 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: ALKERMES PLC.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Alkermes, Inc. | loan | 1 |
| Alkermes PLC | common equity | 1 |
Issuer-level search for “ALKS” → · Compare two funds’ portfolios →